Pure-Shift-Based Proton Magnetic Resonance Spectroscopy for High-Resolution Studies of Biological Samples
-
Published:2024-04-25
Issue:9
Volume:25
Page:4698
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Zhan Haolin12, Chen Yulei1, Cui Yinping1, Zeng Yunsong1, Feng Xiaozhen1ORCID, Tan Chunhua1, Huang Chengda1, Lin Enping1, Huang Yuqing1ORCID, Chen Zhong1
Affiliation:
1. Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, State Key Laboratory of Physical Chemistry of Solid Surfaces, Xiamen University, Xiamen 361005, China 2. Department of Biomedical Engineering, Anhui Provincial Engineering Research Center of Semiconductor Inspection Technology and Instrument, Anhui Province Key Laboratory of Measuring Theory and Precision Instrument, Hefei University of Technology, Hefei 230009, China
Abstract
Proton magnetic resonance spectroscopy (1H MRS) presents a powerful tool for revealing molecular-level metabolite information, complementary to the anatomical insight delivered by magnetic resonance imaging (MRI), thus playing a significant role in in vivo/in vitro biological studies. However, its further applications are generally confined by spectral congestion caused by numerous biological metabolites contained within the limited proton frequency range. Herein, we propose a pure-shift-based 1H localized MRS method as a proof of concept for high-resolution studies of biological samples. Benefitting from the spectral simplification from multiplets to singlet peaks, this method addresses the challenge of spectral congestion encountered in conventional MRS experiments and facilitates metabolite analysis from crowded NMR resonances. The performance of the proposed pure-shift 1H MRS method is demonstrated on different kinds of samples, including brain metabolite phantom and in vitro biological samples of intact pig brain tissue and grape tissue, using a 7.0 T animal MRI scanner. This proposed MRS method is readily implemented in common commercial NMR/MRI instruments because of its generally adopted pulse-sequence modules. Therefore, this study takes a meaningful step for MRS studies toward potential applications in metabolite analysis and disease diagnosis.
Funder
National Natural Science Foundation of China
Reference58 articles.
1. Chowdhury, G.M.I., Behar, K.L., Mason, G.F., Rothman, D.L., and de Graaf, R.A. (2023). Measurement of neuro-energetics and neurotransmission in the rat olfactory bulb using 1H and 1H–[13C] NMR spectroscopy. NMR Biomed. 2. NMR visibility of deuterium-labeled liver glycogen in vivo;Thomas;Magn. Reson. Med.,2021 3. Mohajeri, S., Bezabeh, T., Ijare, O.B., King, S.B., Thomas, M.A., Minuk, G., Lipschitz, J., Kirkpatrick, I., Micflikier, A.B., and Summers, R. (2019). In vivo 1H MRS of human gallbladder bile in understanding the pathophysiology of primary sclerosing cholangitis (PSC): Immune-mediated disease versus bile acid-induced injury. NMR Biomed., 32. 4. Guz, W., Podgórski, R., Bober, Z., Aebisher, D., Truszkiewicz, A., Olek, M., Machorowska Pieniążek, A., Kawczyk-Krupka, A., and Bartusik-Aebisher, D. (2024). In Vitro MRS of cells treated with trastuzumab at 1.5 Tesla. Int. J. Mol. Sci., 25. 5. Singhania, M., Zaher, A., Pulliam, C.F., Bayanbold, K., Searby, C.C., Schoenfeld, J.D., Mapuskar, K.A., Fath, M.A., Allen, B.G., and Spitz, D.R. (2024). Quantitative MRI evaluation of Ferritin overexpression in non-small-cell lung cancer. Int. J. Mol. Sci., 25.
|
|